C
CPIX
Cumberland Pharmaceuticals Inc
3.090
-0.020-0.64%After Hours: 3.090 0.000 0.00%16:10 04/10 EDT
OPEN/PREV CLOSE3.100/3.110
TODAY RANGE3.050-3.124
VOL17.47K
MARKET CAP46.22M
52 WEEK RANGE1.850-6.27
AVG VOL (3M)137.45K
% TURNOVER0.12%
TURNOVER--
P/E (TTM)-16.1865
% RANGE2.37%
EPS(TTM)-0.1909
P/E(FORWARD)37.43
P/B1.858
BVPS1.664
DIVIDEND--
P/S1.038
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP25.90M
SHARES OUTSTANDING14.96M
NEXT EARNINGS05/04-05/08
FREE FLOAT8.38M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·04/02 15:08
SoFi Rolls Out Big Business Banking as It Deepens Blockchain Integration
TipRanks·03/17 13:21
Cumberland announces launch of new Sancuso website
NASDAQ·03/10 17:49
Cumberland Q4 Loss Narrows Y/Y as Talicia Launch Boosts Sales
Reuters·03/09 21:03
Cumberland Pharmaceuticals Inc. Announces Annual Shareholder Meeting
Press release·03/09 14:21
Form 10-K: Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Seeking Alpha·03/04 00:33
Cumberland targets double-digit revenue growth in 2026 as Talicia and Vibativ fuel expansion
NASDAQ·03/03 22:45
Cumberland (CPIX) Q4 2025 Earnings Call Transcript
Reuters·03/03 22:12
Cumberland Pharmaceuticals 2025 revenue rises
Seeking Alpha·03/03 22:11
Cumberland Pharmaceuticals Non-GAAP EPS of $0.11, revenue of $44.5M
Dow Jones·03/03 22:01
*CUMBERLAND PHARMACEUTICALS REPORTS 31% 4Q 2025 Rev GROWTH
Dow Jones·03/03 22:01
*Cumberland Pharma 4Q Rev $13.7M >CPIX
Reuters·03/03 22:00
CUMBERLAND PHARMACEUTICALS REPORTS 31% FOURTH QUARTER 2025 REVENUE GROWTH
Same Industry